Bong Y. Koh, 10% Owner at KalVista Pharmaceuticals, Inc. (KALV), bought 52,492 shares at $12.73 ($668K) on 2024-01-16, disclosed to the SEC on 2024-01-16.
Open-market purchase of $668k KALV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.68 | 6,647 | $84K | 12.6% |
| 2 | $12.68 | 6,647 | $84K | 12.6% |
| 3 | $12.73 | 19,599 | $249K | 37.4% |
| 4 | $12.73 | 19,599 | $249K | 37.4% |
| Total | $12.72 avg | 52,492 | $668K | 100% |
| Filing → |
| TCDA | BUY | 2022-07-14 | $1.6M | — | Filing → |
| KALV | SELL | 2019-03-20 | $14.4M | — | Filing → |
| ABIO | SELL | 2018-02-28 | $1.7M | — | Filing → |